10 Firms Will Steer 6 IPOs Raising $724M To Start February
Law360 (February 1, 2019, 7:15 PM EST) -- Ten firms are scheduled to steer six initial public offerings estimated to raise $724 million for biotechnology firms and blank-check companies during the first week of February, hoping to seize a brief market window following the reopening of the U.S. government.
The issuers represent the year’s first wave of IPO activity, which stalled in January because the partial government shutdown rendered the U.S. Securities and Exchange Commission unable to vet filings. Since the federal government has reopened, several companies that had already publicly filed IPOs and were near ready to conclude deals have resumed their plans.
Asthma drug developer Gossamer Bio...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!